Trasylol Side Effects Could Result In Kidney Failure Lawsuits
Trasylol Side Effects Injury Lawsuits. The Trasylol injury lawyers at our firm are currently investigating instances where heart surgery patients died after being treated with Trasylol. Since the Bayer AG drug was brought to market in 1993, it has been used in a third of all open heart surgeries in the US. However, numerous … [Read more...] about Trasylol Side Effects Could Result In Kidney Failure Lawsuits
Bayer Settling Trasylol Lawsuits
Bayer Trasylol Lawsuits. About 150 Trasylol lawsuits have been settled by Bayer AG for at least $60 million, according to Bloomberg News. According to three anonymous sources, the settlements provide an average payout of about $400,000 per patient, the report said. Recluse By that time, ‘Trasylol’ had been used in a third of all … [Read more...] about Bayer Settling Trasylol Lawsuits
Bayer Failed to Warn of Side Effects
Trasylol Lawsuit Claims Bayer has been sued over Trasylol, a drug used to prevent bleeding during heart bypass surgery that was withdrawn from the market in May 2008. According to MadisonRecord.com, the lawsuit alleges that Bayer did not warn of the possible serious side effects linked to ‘Trasylol’. Trasylol was … [Read more...] about Bayer Failed to Warn of Side Effects
Trasylol Two Lawsuits
Trasylol Named in Two Lawsuits. Trasylol, Bayer AG's now-withdrawn anti-bleeding medication, is the subject in two Illinois lawsuits. One of the plaintiffs claims Trasylol was the cause of her husband's death, and the other alleges the drug caused him to suffer acute renal failure. Bayer permanently withdrew Trasylol from the … [Read more...] about Trasylol Two Lawsuits
Trasylol Named in 78 Lawsuits
Trasylol Named in 78 Lawsuits. Bayer AG has been hit with 78 lawsuits over the drug Trasylol. In November, Bayer suspended Trasylol sales after a Canadian study linked it to a higher risk of death. Trayslol was approved in 1993, and was used to prevent bleeding during open heart surgeries. Since its approval, about a third of … [Read more...] about Trasylol Named in 78 Lawsuits
Trasylol Studies Confirm Death Risks
Trasylol Studies Confirm Death Risks. Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug. Trasylol, manufactured by Bayer AG, was the subject of several Food & Drug Administration (FDA) safety reviews before it was finally pulled from the market last … [Read more...] about Trasylol Studies Confirm Death Risks
Trasylol Drug Combo Linked to Deaths
Drug Combo Linked to Deaths A new Trasylol study is shedding more light on possible reasons behind the drug’s higher-than normal death rate. According to British researchers, while use of the clotting drug aprotinin—known as Trasylol—appears safe during on-pump cardiac surgeries, it appears that combining it with … [Read more...] about Trasylol Drug Combo Linked to Deaths
Trasylol Sales Suspended After Drug Linked to Sudden Death Risk
Trasylol Sales Suspended. Trasylol, a drug used to prevent bleeding during heart surgery, was removed from the market by Bayer AG earlier this month after it was linked to a risk of sudden death. According to the Food & Drug Administration, Trasylol may have been responsible for more than 200 fatalities. The … [Read more...] about Trasylol Sales Suspended After Drug Linked to Sudden Death Risk
Trasylol Pulled From World Market
Trasylol Pulled From World Market. Trasylol, an anti-bleeding medication, was pulled from the market earlier this week following concerns that it put patients at a high risk of death. The German pharmaceutical firm Bayer AG announced that it would stop worldwide sales of Trasylol after a Canadian ‘Trasylol’ study was … [Read more...] about Trasylol Pulled From World Market
Bayer’s Heart-Surgery Drug Increases Risk of Death
Controversial Heart-Surgery Drug Aprotinin Is Under Fire. Bayer’s controversial heart-surgery drug aprotinin, marketed as Trasylol, is under fire yet again thanks to a new study that found that the drug carries with it an increased risk of long-term mortality. Trasylol is a widely used drug intended to reduce bleeding during … [Read more...] about Bayer’s Heart-Surgery Drug Increases Risk of Death
Heart Surgery Drug Linked to Death Risk
Heart Surgery Drug Raise The Risk Of Dying. A drug widely used to prevent excessive bleeding during heart surgery appears to raise the risk of dying in the five years afterward by nearly 50 percent, an international study found. The researchers said replacing the drug aprotinin, sold by Bayer AG under the brand name Trasylol with … [Read more...] about Heart Surgery Drug Linked to Death Risk
FDA Urges Limited Use of Trasylol Pending Review of Data Showing Increased Risks of Heart Attack, Stroke, and Kidney Failure
FDA Urged Doctors To Limit The Use Of Trasyslol. The Food and Drug Administration (FDA) has issued an advisory to doctors urging them to limit the use of Bayer AG’s heart-surgery medication, Trasylol, pending an agency review of research that shows the drug causes increased risks serious medical problems including stroke, heart … [Read more...] about FDA Urges Limited Use of Trasylol Pending Review of Data Showing Increased Risks of Heart Attack, Stroke, and Kidney Failure
FDA Issues Public Health Advisory for Trasylol
FDA Issued An Health Advisory About Trasylol Potential Risks. The Food and Drug Administration today issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has been linked in two scientific … [Read more...] about FDA Issues Public Health Advisory for Trasylol
Bayer’s Trasylol Clotting Drug Boosts Heart Risk, Study Says
Trasylol Double The Risk Of Heart Attack And Stroke. Bayer AG's Trasylol, used in more than 60 countries to control bleeding after surgery, doubles a patient's likelihood of developing kidney failure and increases the risk of heart attacks and strokes, researchers said. Scientists led by Dennis Mangano at the Ischemia Research and … [Read more...] about Bayer’s Trasylol Clotting Drug Boosts Heart Risk, Study Says
